Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction

American Journal of Pathology

Volumn 156, Issue 6, 2000, Pages 1855-1864

  Lehmann, U ^a   Glockner, S ^a   Kleeberger, W ^a   Feist, H ^a   Von Wasielewski, R ^a   Kreipe, H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; QUANTITATIVE ASSAY; STROMA CELL; TISSUE SECTION;

EID: 0033872068     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65059-6     Document Type: Article

References (48)

1. DNA copy number amplifications in human neoplasms: Review of comparative genomic hybridization studies
2. Amplification of oncogenes in human cancer cells
3. Amplification of c-myc but not of c-erbB-2 is associated with high proliferative capacity in breast cancer
4. Amplification of N-myc as a prognostic marker for patients with neuroblastoma
5. c-myc amplification in hepatocellular carcinoma predicts unfavorable prognosis
6. Gene amplification and proliferative kinetics in relation to prognosis of patients with gastric carcinoma
7. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: Poor prognosis in node-negative breast carcinomas
8. Gene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas
9. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
10. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: Definition of phenotypic groups
11. Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer
12. Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation
13. Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer
14. Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer
15. Overexpression of the Tpl-2/Cot oncogene in human breast cancer
16. Amplification and overexpression of peroxisome proliferator-activated receptor binding protein (PBP/PPARBP) gene in breast cancer
17. Multistep carcinogenesis of breast cancer and tumour heterogeneity
18. ERBB2 oncogene in human breast cancer and its clinical significance
19. HER-2/neu (c-erb-B2) gene and protein in breast cancer
20. Identification of expressed genes by laser-mediated manipulation of single cells
21. A novel method for real time quantitative RT-PCR
22. Real time quantitative PCR
23. Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors
24. DNA topoisomerases
25. Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities
26. The biology of erbB-2/neu/HER-2 and its role in cancer
27. ERBB-2 (HER2/neu) gene copy number, p185HER-2 overexpression, and intratumor heterogeneity in human breast cancer
28. Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization
29. A new proliferation-associated nuclear antigen delectable in paraffin- embedded tissues by the monoclonal antibody Ki-S1
30. Proliferation-associated nuclear antigen Ki-S1 is identical with topoisomerase II alpha. Delineation of a carboxy-terminal epitope with peptide antibodies
31. Detection of specific polymerase chain reaction product by utilizing the 5'-3' exonuclease activity of Thermus aquaticus DNA polymerase
32. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization
33. Novel approach to quantitative polymerase chain reaction using real- time detection: Application to the detection of gene amplification in breast cancer
34. Improved quantitation of HER-2/neu gene copy number in breast tumor- derived DNA samples
35. Association of c-erbB2-gene amplification with poor prognosis in non- inflammatory breast carcinomas but not in carcinomas of the inflammatory type
36. Detection of specific sequences among DNA fragments separated by gel electrophoresis
37. Technical aspects of quantitative competitive PCR
38. Quantitative RT-PCR: Pitfalls and potential
39. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization
40. DNA in situ hybridization as an adjunct in tumor diagnosis
41. HER-2/neu testing comes of age
42. The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: From orphanhood to multiple stromal ligands
43. Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer
44. Co-amplification of erbB2, topoisomerase II alpha and retinoic acid receptor alpha genes in breast cancer and allelic loss at topoisomerase I on chromosome 20
45. Topoisomerase II alpha co-amplification with erbB2 in human primary breast cancer and breast cancer cell lines: Relationship to m-AMSA and mitoxantrone sensitivity
46. Universal amplification of DNA isolated from small regions of paraffin-embedded, formalin-fixed tissue